Quantcast

Latest placebo Stories

2014-11-25 16:27:52

Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo THOUSAND OAKS, Calif. and LONDON, Nov.

2014-11-19 08:27:30

Randomized Controlled Trial Conducted at the Santa Casa de Sao Paulo School of Medicine in Brazil LOS ANGELES, Nov.

2014-11-18 08:33:37

Phase II Results Unveiled at 2014 American College of Rheumatology Annual Meeting TUSCALOOSA, Ala. and BOSTON, Nov.

2014-11-17 08:32:28

Depression Biomarker Analysis Shows NSI-189 is Rapidly and Persistently Efficacious GERMANTOWN, Md., Nov. 17, 2014 /PRNewswire/ -- Neuralstem, Inc.

2014-11-17 08:29:40

LOS ANGELES, Nov. 17, 2014 /PRNewswire/ -- NeuroSigma®, Inc.

2014-11-16 16:21:13

- Secukinumab met primary endpoints demonstrating statistically significant improvements versus placebo in signs and symptoms of active psoriatic arthritis (PsA) in two pivotal Phase III studies

2014-11-15 16:21:18

- Secukinumab is the first selective IL-17A inhibitor to significantly improve signs and symptoms of ankylosing spondylitis (AS) versus placebo in Phase III studies EAST HANOVER, N.J., Nov.

2014-11-12 08:32:30

ENGLEWOOD, Colo., Nov. 12, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

2014-11-11 08:32:22

- Study successfully meets primary endpoint- Lack of sleep-related side effects supports flexible nighttime dosing platform to target control over symptoms during the morning routine-

2014-11-11 00:21:52

Dupilumab Demonstrated Improvement in Lung Function, Reductions of Severe Exacerbations TARRYTOWN, N.Y. and PARIS, Nov. 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.